8 completed. 8 Phase 2, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 8 | Completed 8 |
| Phase 1 | 1 | Completed 1 |
Follow Nausea and Vomiting: new trials by email Literature Review of Nausea and Vomiting trials Research Report on Nausea and Vomiting
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Effect of Glycopyrrolate on Nausea and Vomiting After ERCP Operation Glycopyrrolate, Anisodamine - Nausea and Vomiting | Phase 1 / Phase 2 | Completed | Jie Chen | 130 | 2023-10-01 | 2024-09-05 |
| Effect of Inhaled Aromatherapy on Chemo-Induced Nausea Vomiting (NCVI): CINVAROM (Chemotherapy Induced Nausea Vomiting and AROMatherapy) Essential oils - Nausea and Vomiting, Aromatherapy | Phase 2 | Completed | Centre Francois Baclesse | 96 | 2020-12-14 | 2026-08-17 |
| Phase II Trial of Aprepitant & Palonosetron for CINV Prevention w FOLFOX aprepitant, dexamethasone, fluorouracil - Colorectal Cancer, Nausea and Vomiting | Phase 2 | Completed | OHSU Knight Cancer Institute | 54 | 2006-06-01 | 2017-06-12 |
| Ondansetron vs Prochlorperazine for Nausea and Vomiting in the Emergency Department Prochlorperazine, Ondansetron - Nausea and Vomiting | Phase 2 | Completed | Emory University | 64 | 2005-03-01 | 2014-05-19 |
| Study for The Prevention Of Nausea in Cancer Patients Receiving Highly Emetogenic Cisplatin Based Chemotherapy Aprepitant, Ondansetron, GW679769 - Nausea and Vomiting, Chemotherapy-Induced | Phase 2 | Completed | GlaxoSmithKline | 492 | 2005-02-01 | 2010-05-10 |
| UMCCOP 02-01 Ginger in Treating Nausea and Vomiting in Patients Receiving Chemotherapy for Cancer ginger extract, placebo - Nausea and Vomiting, Unspecified Adult Solid Tumor, Protocol Specific | Phase 2 | Completed | University of Michigan Rogel Cancer Center | 180 | 2003-05-01 | 2016-10-21 |
| Acupressure and Acustimulation Wrist Bands for the Prevention of Nausea and Vomiting Caused by Chemotherapy dolasetron mesylate, granisetron hydrochloride, ondansetron - Nausea and Vomiting, Unspecified Adult Solid Tumor, Protocol Specific | Phase 2 | Completed | Gary Morrow | 700 | 1999-10-01 | 2015-10-15 |
| Octreotide as Palliative Therapy for Cancer-Related Bowel Obstruction That Cannot Be Removed by Surgery octreotide acetate - Colorectal Cancer, Constipation, Impaction, and Bowel Obstruction | Phase 2 | Completed | Northwestern University | 1999-10-01 | 2012-06-06 |
Nausea (8) · Vomiting (8) · Colonic Neoplasms (2) · Colorectal Neoplasms (2) · Rectal Neoplasms (2) · Bile Duct Neoplasms (1) · Carcinoma, Ovarian Epithelial (1) · Constipation (1) · Gastrointestinal Stromal Tumors (1) · Intestinal Obstruction (1) · Ovarian Neoplasms (1) · Pancreatic Neoplasms (1) · Stomach Neoplasms (1)
Pathological Conditions, Signs and Symptoms (8) · Signs and Symptoms (8) · Signs and Symptoms, Digestive (8) · Colonic Diseases (2) · Digestive System Diseases (2) · Digestive System Neoplasms (2) · Gastrointestinal Diseases (2) · Gastrointestinal Neoplasms (2) · Intestinal Diseases (2) · Intestinal Neoplasms (2) · Neoplasms (2) · Neoplasms by Site (2) · Rectal Diseases (2) · Adnexal Diseases (1) · Bile Duct Diseases (1)
Ondansetron (3) · Aprepitant (2) · Dexamethasone (2) · Fluorouracil (1) · Glycopyrrolate (1) · Granisetron (1) · Irinotecan (1) · L 758298 (1) · Leucovorin (1) · Octreotide (1) · Oils, Volatile (1) · Oxaliplatin (1) · Palonosetron (1) · Prochlorperazine (1) · Tropisetron (1)
Centre Francois Baclesse (1) · Emory University (1) · Gary Morrow (1) · GlaxoSmithKline (1) · Jie Chen (1) · Northwestern University (1) · OHSU Knight Cancer Institute (1) · University of Michigan Rogel Cancer Center (1)
United States (5) · Argentina (1) · Austria (1) · Belgium (1) · Chile (1) · China (1) · Croatia (1) · Czechia (1) · France (1) · Hong Kong (1) · Hungary (1) · Italy (1) · Mexico (1) · Netherlands (1) · Pakistan (1)
Daniel T Wu, MD (1) · Gary R. Morrow, PhD, MS (1) · Guangyou Duan, doctor (1) · J. Cameron Muir, MD (1) · John Patka, PharmD (1) · Joseph Bubalo, PharmD, BCPS, BCOP (1) · Suzanna Zick, MPH, ND (1)
P30CA046592 (1)